Yesterday we completed part 2 of our Safety Biomarkers and Pharmacovigilance webinar.
We covered some great topics:
- The utility of safety biomarkers throughout the drug development process
- The regulatory framework for biomarker qualification
- Insight into how to identify biomarker information from the literature
- The role of biomarkers in post-marketing pharmacovigilance practices
To view the recording and download the slide deck click the button below:
